takedaTakeda Russia-CIS (in the past Nycomed Russia-CIS) is a part of Takeda Pharmaceutical Company Limited (Takeda) since September 2011. As the largest pharmaceutical company in Japan and a leader in the global industry, Takeda’s mission is to strive toward better health for patients worldwide through leading innovation in medicine.

It has a commercial presence in around 70 countries, with particular strength in Asia, North America, Europe and fast-growing emerging markets including Latin America, Russia-CIS and China. Areas of focus include cardiovascular and metabolic diseases, immunology and respiratory

diseases, oncology and central nervous system diseases, among others. Takeda is ranked 12th by global Rx sales, 14th in the BRIC countries and 18th in Europe. Takeda is one of the top ten pharmaceutical companies in Russia by sales.





Bayer is a German pharmaceutical concern, founded back in 1851. The manufacturer has come a long way from a retail pharmacy to the leader of the European and world market of pharmaceuticals.

The company has its own research base, specializing in the fields of andrology, gynecology, oncology, diagnostic imaging. Regular researches are carried out in methods of therapies of diseases, the consequence of which is disability. The reputation of the concern is very high, the goods are characterized by efficiency and maximum safety.

It was acetylsalicylic acid (first discovered by French chemist Charles Gerard 1852) which was the first major product of the company - a modification of salicylic acid or salicylate, folk medicine, which was extracted from the bark of willow trees.

Women's health, especially reproductive health is one of the key areas of activities of the company Bayer. The main sphere of its competence is hormonal contraception, menopause and gynecological diseases.

Bayer continues research and elaborations aimed at finding innovative contraceptive technologies, in order to improve women's health.

In the last decade, the development of new products has allowed to expand significantly the choice of drugs and offer new contraceptives with additional advantages, with new reception mode 24 + 4, with flexible reception mode, including folate in contraceptive drugs, which are among the most important vitamins of group B.
But the research did not stop there ...

In Armenia, Bayer began its activities in 1995 and is still successfully using the latest scientific achievements to solve major globalissues; it offers innovative elaborations which are capable to meet the actual needs of customers.








Exposition of the exhibition: during the conference will be organized thematic exposition of producers and distributors of pharmaceutical products, medical products and equipment, diagnostic tools, products of medical purpose, IT specialists and professional press. Information about the format and price of your participation will be sent to you on your request.

Participation in the Congress as a partner will allow to present your company more effectively to target audience, to tell about the scientific achievements and the research results confirming the high efficiency of your products, as well as:

  • to strengthen the target audience loyalty to your brand;
  • to strengthen your company position in the market and to provide the advantage of it in a competitive environment;
  • to enhance the image of «a successful brand»;
  • to expand existing business relations.

We invite to take part in the Congress: endocrinologists, urologists, andrologists, sexologists, gynecologists, therapist-nutritionists, neurologists, cardiologists, psychologists, dermatocosmetologists, gerontologists, doctors, residents and postgraduates of all medical specialization who are interested in the issues of male and female health, hormonetherapy and medicine of prophylactics in the 21st century.

Amount of participants: 350-400 per.

Information about the ways of participation and prices will be provided by your request.

Project manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
+7 (916) 130 6491